Beyond First Line: Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis

Expert faculty discuss the pharmacist’s role in the treatment of myelofibrosis with an on-demand webcast of a live symposium, downloadable slides, and commentary.

Share

Program Content

Activities

Novel Therapy for MF
Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 23, 2023

Activities

Novel Therapy for MF
Beyond First Line: Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2023

Expires: June 22, 2024

Activities

MF Treatment
Pharmacists Discuss Practical Considerations and Novel Treatment Options for Patients With Myelofibrosis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2023

Faculty

cover img faculity

Justin R. Arnall, PharmD, BCOP

Clinical Coordinator, Hematology
Atrium Health Specialty Pharmacy Service
Charlotte, North Carolina

cover img faculity

Victoria Nachar, PharmD, BCOP

Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan

Provided by

ProCE Banner

Provided by ProCE, LLC

Supporters

Supported by an educational grant from GSK.

GSK

Partners

Clinical Care Options, LLC

ProCE Banner

Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner

 In partnership with Clinical Care Options, LLC and the Hematology/Oncology Pharmacy Association (HOPA)

Additional Information

In coordination with HOPA's Annual Conference